We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together.
We aim to positively impact the health of more than 2.5 billion individuals by 2031, with ambitious plans for growth and continuing to make GSK a company where everyone can thrive.
We prevent and treat disease with vaccines, specialty and general medicines.
We focus on science of the immune system and advanced technologies, investing in 4 core therapeutic areas (Infectious Diseases, HIV, Respiratory/Immunology and Oncology) to impact health at scale.
